Prothena (PRTA) Expected to Announce Quarterly Earnings on MondayMarket Beat·21 hours agoPRTA-0.57%DB+2.42%
Analyst Reiterates Buy on Prothena, Maintains $30 Price Target on Differentiated TTR-Depleter OpportunityTip Ranks·Jul 24 at 07:25 AMPRTA-0.57%RPRX-0.17%
The Biotech Survival Curve: How Milestone Checks and In-Vivo CRISPR Are Rewriting the RulesGlobal Report·Jul 4 at 04:01 AMPRTA-0.57%EDIT+3.08%
Prothena 10% owner William P. Scully buys 20,000 shares worth $157,990PUBT·Jun 18 at 10:39 AMPRTA-0.57%
Insider Buying: Prothena (NASDAQ:PRTA) Major Shareholder Acquires 125,000 Shares of StockMarket Beat·Jun 13 at 06:03 AMPRTA-0.57%
Major Prothena Investor Makes Bold New Move in the MarketTip Ranks·Jun 5 at 09:09 PMPRTA-0.57%NVO+1.85%
Analyst Reiterates Buy on Prothena, Maintaining $30 Price Target on CYTOPE and PRX012-TfR Platform StrengthTip Ranks·May 8 at 01:46 PMPRTA-0.57%SBIO+1.11%
Prothena | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 51.08 MEarnings Watch·May 7 at 10:37 PMPRTA-0.57%
Prothena (PRTA) to Release Quarterly Earnings on ThursdayMarket Beat·May 3 at 05:18 AMPRTA-0.57%IBBQ+0.43%
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga_article·Apr 27 at 04:05 PMTRVI+3.34%ADVB-24.34%
